Literature DB >> 9698478

Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection.

J W Kim1, S E Namkoong, S W Ryu, H S Kim, J W Shin, J M Lee, D H Kim, I K Kim.   

Abstract

OBJECTIVE: Alterations of the p15INK4B and p16INK4A gene which are separated by 25 kb on chromosome 9p21 have been reported in various tumor-derived cell lines and primary tumors, but the role of these genes in cervical cancer is unknown. To determine the frequency of deletions and point mutations of these genes in human cervical cancer, we examined for alterations of the p15INK4B and p16INK4A genes in cervical carcinomas.
METHODS: We examined 57 primary tumors and matched normal tissues and 3 cervical cancer-derived cell lines. All the tumor tissues and cell lines were human papillomavirus (HPV) positive. Deletions or point mutations of exon 2 of the pINK4B gene and exons 1, 2, and 3 of the p16INK3A gene were examined by polymerase chain reaction and direct sequencing, respectively.
RESULTS: Our data indicate no evidence for intragenic homozygous deletion or point mutation in the primary cervical cancer tissues or cancer-derived cell lines.
CONCLUSION: Deletions or point mutations in the p15INK4B or p16INK4A gene may not be required for the development of HPV-positive cervical cancer or for establishment of cervical cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9698478     DOI: 10.1006/gyno.1998.5041

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.

Authors:  Jens P Klussmann; Elif Gültekin; Soenke J Weissenborn; Ulrike Wieland; Volker Dries; Hans P Dienes; Hans E Eckel; Herbert J Pfister; Pawel G Fuchs
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 2.  p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.

Authors:  I Tsoumpou; M Arbyn; M Kyrgiou; N Wentzensen; G Koliopoulos; P Martin-Hirsch; V Malamou-Mitsi; E Paraskevaidis
Journal:  Cancer Treat Rev       Date:  2009-03-03       Impact factor: 12.111

3.  Alteration of p16 and p15 genes in human uterine tumours.

Authors:  R Nakashima; M Fujita; T Enomoto; T Haba; K Yoshino; H Wada; H Kurachi; M Sasaki; K Wakasa; M Inoue; G Buzard; Y Murata
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

Review 4.  The molecular genetics of cervical carcinoma.

Authors:  P A Lazo
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

5.  Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma.

Authors:  Ruth Holm; Mette Førsund; Mai T Nguyen; Jahn M Nesland; Claes G Trope
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

6.  Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia.

Authors:  Ashleen Shadeo; Raj Chari; Kim M Lonergan; Andrea Pusic; Dianne Miller; Tom Ehlen; Dirk Van Niekerk; Jasenka Matisic; Rebecca Richards-Kortum; Michele Follen; Martial Guillaud; Wan L Lam; Calum MacAulay
Journal:  BMC Genomics       Date:  2008-02-04       Impact factor: 3.969

7.  Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer.

Authors:  S F Preuss; A Weinell; M Molitor; M Stenner; R Semrau; U Drebber; S J Weissenborn; E J M Speel; C Wittekindt; O Guntinas-Lichius; T K Hoffmann; G D Eslick; J P Klussmann
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.